Bevacizumab and Trabectedin +/- Carboplatin in Advanced Ovarian Cancer

Clinical trial NCT01735071 · COMPLETED

Trial details

NCT number: NCT01735071
Sponsor: Mario Negri Institute for Pharmacological Research
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Ovarian Epithelial Cancer Recurrent

Start date: 2013-07-01
Primary completion: 2018-03-18
Enrollment: 71

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.